Merck Kgaa (MKGAF) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck Kgaa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.878 Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference call 00:00:04.878 -- 00:00:10.026 on third quarter 2025. At any time during the conference, you can 00:00:10.026 -- 00:00:14.873 press star 1 1 to enter the queue for the question and answer session. 00:00:14.873 -- 00:00:18.898 As a reminder, all participants will be in a listen only mode. 00:00:18.898 -- 00:00:20.781 Please note this is our customer's request. 00:00:20.781 -- 00:00:25.829 This conference will be recorded. I'm now handing over to Florian Schroeder, 00:00:25.829 -- 00:00:29.208 Head of Investor Relations, who will lead you through this conference. 00:00:29.208 -- 00:00:31.731 Please go ahead, sir. 00:00:31.731 -- 00:00:37.679 Thank you so much, Sarah. And a sincere welcome to everyone joining the Merck Q3 25 00:00:37.679 -- 00:00:43.007 results call. I'm Florian Schreder, the head of investor relations at Merck. 00:00:43.007 -- 00:00:48.274 I'm delighted to be here today with Belen Garrigio, our group CEO, and Helene von Röder, 00:00:48.274 -- 00:00:50.457 our group CFO. 00:00:50.457 -- 00:00:55.544 During the Q&A part of this call, we will also be joined by Kai Beckmann, CEO of 00:00:55.544 -- 00:01:01.380 Electronics and Deputy Chair of the Executive Board, Jean-Charles Wirth, CEO of LifeScience, 00:01:01.380 -- 00:01:06.445 and Danny Bazohar, CEO of Healthcare. In the first few minutes, we will walk 00:01:06.445 -- 00:01:09.368 you through the key slides of our presentation. 00:01:09.368 -- 00:01:12.551 After that, we will be happy to take your questions. 00:01:12.551 -- 00:01:16.853 Now, I will turn it over to Belen to get us started. 00:01:17.756 -- 00:01:22.300 Thank you, Florian. Good afternoon and welcome everybody to our Q3 ear...